Marketdash
Back to Stock Market News

Big Winners on Tuesday: Novo Nordisk Soars on Wegovy Pill Approval

MarketDash Editorial Team
2 hours ago
Novo Nordisk jumped 8.6% after the FDA approved its first-of-its-kind GLP-1 pill, while other big movers included WW International, Sable Offshore, and StoneCo as markets traded slightly lower on Tuesday.

While U.S. markets treaded water on Tuesday with the Dow Jones index slipping around 0.1%, a number of individual stocks posted impressive gains throughout the session.

Novo Nordisk Leads the Charge

The standout performer was Novo Nordisk A/S (NVO), which rallied sharply after receiving approval from the U.S. Food and Drug Administration for its Wegovy pill. This marks the first approval of a GLP-1 pill globally, representing a significant milestone in obesity treatment. Shares jumped 8.6% to $52.26 on Tuesday.

The approval created a ripple effect across related companies. WW International Inc (WW) shares jumped 14.4% to $30.42, benefiting from its recently launched integrated GLP-1 program that positions Weight Watchers in the rapidly expanding weight-loss medication market.

Other Notable Gainers

Several other stocks posted solid gains during the session. Sable Offshore Corp (SOC) climbed 8.8% to $8.27 after announcing that the US Pipeline and Hazardous Materials Safety Administration approved the restart plans for the Las Flores Pipeline system.

ZIM Integrated Shipping Services Ltd (ZIM) shares rose 7.4% to $21.35 after the company disclosed it received proposals from multiple parties to acquire all outstanding shares and is currently evaluating the offers.

Lionsgate Studios Corp (LION) shares surged 8.3% to $9.06. The entertainment company recently expanded access to its ad-supported streaming inventory, part of the broader shift toward advertising-based streaming models.

StoneCo Ltd (STNE) gained 5.8% to $14.96 after the Brazilian payments company's board authorized a new share repurchase program, under which Stone may repurchase up to R$2 billion in outstanding Class A common shares.

Mining and Metals Sector Strength

The mining and metals sector saw broad-based strength. Lifezone Metals Ltd (LZM) gained 11.1% to $4.43, while Hycroft Mining Holding Corporation (HYMC) gained 9.1% to $26.75.

Critical Metals Corp (CRML) gained 7.6% to $8.65, and Intrepid Potash Inc (IPI) shares rose 7.1% to $29.06.

Century Aluminum Co (CENX) rose 5% to $39.02. Wells Fargo analyst Timna Tanners maintained Century Aluminum with an Overweight rating and raised the price target from $37 to $46.

Additional Movers

Ascentage Pharma Group International (AAPG) gained 8.4% to $28.17, while mF International Limited (MFI) gained 7.1% to $21.38.

Sellas Life Sciences Group Inc (SLS) gained 6.8% to $2.82 as biotech stocks showed strength throughout the session.

The divergence between the broader market's modest decline and these individual stock performances highlights how company-specific catalysts like regulatory approvals, strategic announcements, and analyst upgrades can drive significant moves even when overall market sentiment remains tepid.

Back to Stock Market News

Big Winners on Tuesday: Novo Nordisk Soars on Wegovy Pill Approval

MarketDash Editorial Team
2 hours ago
Novo Nordisk jumped 8.6% after the FDA approved its first-of-its-kind GLP-1 pill, while other big movers included WW International, Sable Offshore, and StoneCo as markets traded slightly lower on Tuesday.

While U.S. markets treaded water on Tuesday with the Dow Jones index slipping around 0.1%, a number of individual stocks posted impressive gains throughout the session.

Novo Nordisk Leads the Charge

The standout performer was Novo Nordisk A/S (NVO), which rallied sharply after receiving approval from the U.S. Food and Drug Administration for its Wegovy pill. This marks the first approval of a GLP-1 pill globally, representing a significant milestone in obesity treatment. Shares jumped 8.6% to $52.26 on Tuesday.

The approval created a ripple effect across related companies. WW International Inc (WW) shares jumped 14.4% to $30.42, benefiting from its recently launched integrated GLP-1 program that positions Weight Watchers in the rapidly expanding weight-loss medication market.

Other Notable Gainers

Several other stocks posted solid gains during the session. Sable Offshore Corp (SOC) climbed 8.8% to $8.27 after announcing that the US Pipeline and Hazardous Materials Safety Administration approved the restart plans for the Las Flores Pipeline system.

ZIM Integrated Shipping Services Ltd (ZIM) shares rose 7.4% to $21.35 after the company disclosed it received proposals from multiple parties to acquire all outstanding shares and is currently evaluating the offers.

Lionsgate Studios Corp (LION) shares surged 8.3% to $9.06. The entertainment company recently expanded access to its ad-supported streaming inventory, part of the broader shift toward advertising-based streaming models.

StoneCo Ltd (STNE) gained 5.8% to $14.96 after the Brazilian payments company's board authorized a new share repurchase program, under which Stone may repurchase up to R$2 billion in outstanding Class A common shares.

Mining and Metals Sector Strength

The mining and metals sector saw broad-based strength. Lifezone Metals Ltd (LZM) gained 11.1% to $4.43, while Hycroft Mining Holding Corporation (HYMC) gained 9.1% to $26.75.

Critical Metals Corp (CRML) gained 7.6% to $8.65, and Intrepid Potash Inc (IPI) shares rose 7.1% to $29.06.

Century Aluminum Co (CENX) rose 5% to $39.02. Wells Fargo analyst Timna Tanners maintained Century Aluminum with an Overweight rating and raised the price target from $37 to $46.

Additional Movers

Ascentage Pharma Group International (AAPG) gained 8.4% to $28.17, while mF International Limited (MFI) gained 7.1% to $21.38.

Sellas Life Sciences Group Inc (SLS) gained 6.8% to $2.82 as biotech stocks showed strength throughout the session.

The divergence between the broader market's modest decline and these individual stock performances highlights how company-specific catalysts like regulatory approvals, strategic announcements, and analyst upgrades can drive significant moves even when overall market sentiment remains tepid.